Which has grown faster, AZN or GILD?

Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus GILD at 2.72%.

Does AZN or GILD pay a bigger dividend?

AZN yields 2.02% and GILD yields 2.22% based on trailing dividends and the latest price.

Is AZN or GILD more profitable?

AZN runs the higher net margin — AZN at 17.02% versus GILD at -10.64%.

How have AZN and GILD total returns compared?

Over the past 10 years, AZN delivered 12.85% and GILD delivered 10.21% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Gilead Sciences, Inc. (GILD)

A side-by-side comparison of AstraZeneca PLC and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$248.40B

$160.17HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

GILD

Gilead Sciences, Inc.

$178.44B

$143.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — AZN vs GILD

growth of $100 · dividends reinvested · last 10y

AZN +217.1% (+12.2%/yr)GILD +161.3% (+10.1%/yr)AZN compounded faster over this window

AZN GILD

AZN vs GILD: by the numbers

•AZN is the larger company ($248.40B vs $178.44B market cap).
•AZN is profitable (17.02% net margin) while GILD runs a net loss (-10.64%).
•AZN grew revenue faster over the past five years (15.76% vs 2.72% CAGR).
•GILD pays the higher dividend yield (2.22% vs 2.02%).

Metrics side by side

Valuation

Metric	AZN	GILD
P/E ratio	24.05	N/A
Forward P/E	15.64	N/A
P/S ratio	4.05	5.86
P/B ratio	4.94	15.09
EV / EBITDA	13.56	N/A
FCF yield	3.52%	7.27%

Profitability

Metric	AZN	GILD
Gross margin	81.88%	79.59%
Operating margin	22.77%	39.74%
Net margin	17.02%	-10.64%
ROE	20.79%	-27.39%
ROIC	12.83%	-3.66%

Dividends

Metric	AZN	GILD
Dividend yield	2.02%	2.22%
Payout ratio	48.50%	N/A

Growth (annualized)

Metric	AZN	GILD
Revenue CAGR (5Y)	15.76%	2.72%
EPS CAGR (5Y)	22.02%	133.83%
FCF CAGR (5Y)	14.53%	9.27%
Total return CAGR (5Y)	9.46%	19.60%

Frequently asked

Which has grown faster, AZN or GILD?: Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus GILD at 2.72%.
Does AZN or GILD pay a bigger dividend?: AZN yields 2.02% and GILD yields 2.22% based on trailing dividends and the latest price.
Is AZN or GILD more profitable?: AZN runs the higher net margin — AZN at 17.02% versus GILD at -10.64%.
How have AZN and GILD total returns compared?: Over the past 10 years, AZN delivered 12.85% and GILD delivered 10.21% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full GILD analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio AstraZeneca dividend yield Gilead Sciences dividend yield AstraZeneca ROE Gilead Sciences ROE AstraZeneca operating margin Gilead Sciences operating margin AstraZeneca revenue growth Gilead Sciences revenue growth AstraZeneca free cash flow Gilead Sciences free cash flow

AstraZeneca & Gilead Sciences appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.